The clinical data supporting the 1 mg dose is robust. In the landmark SUSTAIN clinical trial program, the 1 mg dose demonstrated superior reductions in HbA1c compared to sitagliptin, exenatide, and insulin glargine. However, the cultural explosion of Ozempic is inextricably linked to its secondary effect: weight loss. The 1 mg dose has become the "goal" for many patients, including those using the drug off-label for obesity (where the higher-dose Wegovy is technically indicated).
: Used alongside diet and exercise to lower A1C levels. ozempic 1 mg dose pen
Each 1 mg pen usually contains 4 mg of semaglutide in 3 mL of solution, providing four separate 1 mg doses (a one-month supply). How to Use the Ozempic 1 mg Pen The clinical data supporting the 1 mg dose is robust